These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Why the world needs another malaria initiative. Lancet; 2004 Jul 31-Aug 6; 364(9432):389-90. PubMed ID: 15288715 [No Abstract] [Full Text] [Related]
30. Therapeutic efficacy of artemisinin combination therapies and prevalence of S769N mutation in PfATPase6 gene of Plasmodium falciparum in Kolkata, India. Saha P; Naskar A; Ganguly S; Das S; Guha SK; Biswas A; Bera DK; Kundu PK; Das M; Mullick S; Ray K; Maji AK Asian Pac J Trop Med; 2013 Jun; 6(6):443-8. PubMed ID: 23711703 [TBL] [Abstract][Full Text] [Related]
31. Artemisinin resistance in Myanmar--Authors' reply. Imwong M; Tun KM; Hlaing TM; Grist EP; Guerin P; Smithuis F; Dondorp AM; Day NP; Nosten F; White N; Woodrow CJ Lancet Infect Dis; 2015 Sep; 15(9):1002-1003. PubMed ID: 26333325 [No Abstract] [Full Text] [Related]
32. Artemisinin resistance needs to be defined rigorously to be understood: response to Dondorp and Ringwald. Krishna S; Kremsner PG Trends Parasitol; 2013 Aug; 29(8):361-2. PubMed ID: 23809865 [No Abstract] [Full Text] [Related]
33. Once-daily combination therapy for uncomplicated malaria: is this the way forward? Kokwaro G Clin Infect Dis; 2005 Aug; 41(4):433-4. PubMed ID: 16028148 [No Abstract] [Full Text] [Related]
34. Updates on k13 mutant alleles for artemisinin resistance in Plasmodium falciparum. Zaw MT; Emran NA; Lin Z J Microbiol Immunol Infect; 2018 Apr; 51(2):159-165. PubMed ID: 28711439 [TBL] [Abstract][Full Text] [Related]
35. Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases. Ajayi NA; Ukwaja KN Rev Soc Bras Med Trop; 2013; 46(4):525-7. PubMed ID: 23982103 [TBL] [Abstract][Full Text] [Related]
36. A call to action: addressing the challenge of artemisinin-resistant malaria. Kachur SP; MacArthur JR; Slutsker L Expert Rev Anti Infect Ther; 2010 Apr; 8(4):365-6. PubMed ID: 20377330 [No Abstract] [Full Text] [Related]
37. Emerging artemisinin resistance in the border areas of Thailand. Na-Bangchang K; Karbwang J Expert Rev Clin Pharmacol; 2013 May; 6(3):307-22. PubMed ID: 23656342 [TBL] [Abstract][Full Text] [Related]
38. Neuroauditory toxicity of artemisinin combination therapies-have safety concerns been addressed? Ramos-Martín V; González-Martínez C; Mackenzie I; Schmutzhard J; Pace C; Lalloo DG; Terlouw DJ Am J Trop Med Hyg; 2014 Jul; 91(1):62-73. PubMed ID: 24865683 [TBL] [Abstract][Full Text] [Related]
39. Artemisinin resistance is a clear and present danger. Dondorp AM; Ringwald P Trends Parasitol; 2013 Aug; 29(8):359-60. PubMed ID: 23768981 [No Abstract] [Full Text] [Related]
40. Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations. Tindana P; de Haan F; Amaratunga C; Dhorda M; van der Pluijm RW; Dondorp AM; Cheah PY Malar J; 2021 Feb; 20(1):119. PubMed ID: 33639946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]